Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Main Study	STARTED	AK002 SC 300 mg (Main Study) - AK002 Continuing (OLE)	65
Main Study	STARTED	Placebo (Main Study) - Placebo Rollover (OLE)	65
Main Study	COMPLETED	AK002 SC 300 mg (Main Study) - AK002 Continuing (OLE)	57
Main Study	COMPLETED	Placebo (Main Study) - Placebo Rollover (OLE)	58
Main Study	NOT COMPLETED	AK002 SC 300 mg (Main Study) - AK002 Continuing (OLE)	8
Main Study	NOT COMPLETED	Placebo (Main Study) - Placebo Rollover (OLE)	7
Open-Label Extension	STARTED	AK002 SC 300 mg (Main Study) - AK002 Continuing (OLE)	55
Open-Label Extension	STARTED	Placebo (Main Study) - Placebo Rollover (OLE)	57
Open-Label Extension	COMPLETED	AK002 SC 300 mg (Main Study) - AK002 Continuing (OLE)	32
Open-Label Extension	COMPLETED	Placebo (Main Study) - Placebo Rollover (OLE)	36
Open-Label Extension	NOT COMPLETED	AK002 SC 300 mg (Main Study) - AK002 Continuing (OLE)	23
Open-Label Extension	NOT COMPLETED	Placebo (Main Study) - Placebo Rollover (OLE)	21

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05155085/flow